Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact email@example.com.
Sex-Bias in COVID-19: A Meta-Analysis and Review of Sex Differences in Disease and Immunity
24 Pages Posted: 22 Apr 2020More...
Background: There have been anecdotal reports of a male sex bias in COVID-19. We aimed to perform a meta-analysis of available case reports to investigate whether there was a difference in the proportion of males and females infected with COVID-19 and whether sex associated with a difference in risk of ITU admission or death.
Methods: We performed a meta-analysis of 29 reports. An internet search was performed for reports in any language that included sex as a variable when describing case numbers, ITU admissions or death between 01.01.20-30.03.20. Reports were excluded if they did not reported the sex difference in overall case numbers or where there was possible duplication. Summary level data were extracted from reports. Meta-analyses were used to assess the proportion of males and females in total numbers of confirmed cases, to estimate odds ratios (ORs) with 95% CI associated with sex for ITU admission and death based on pooled average effect measures that were weighted according to the size and precision of each report. Fixed and random effects models were estimated.
Findings: 29 studies were eligible with a total of 206,128 cases. The proportion of male cases with COVID-19 was 0.52 (95% CI=0.50,0.53, p=0.12 for random effects model). Male sex associated with an increased risk of ITU admission (OR=2.50, 95% CI=2.25,2.78; 7.3e-64 for random effects model; n=43,075). Male sex associated with an increased risk of mortality (OR=1.60, 95% CI=1.41, 1.82, p=7.4e-13 for random effects model; n=170,983).
Funding Statement: KW is funded by the Crick African Network, African Career Accelerator Award (CANB0001/01). This work is funded by a Centre of Excellence (Centre for Adolescent Rheumatology Versus Arthritis) grant to LRW (21593) as well as grants from Medical Research Council (MR/R013926/1) and Great Ormond Street Children’s Charity to LRW . ECR and NdG are supported by a Medical Research Foundation Lupus Fellowship to ECR (MRF-057-0001-RGROSS-C0797). LRW is supported by the NIHR Biomedical Research Centre at Great Ormond Street Hospital. HP is supported by a Versus Arthritis Studentship to CC (22203)
Declaration of Interests: The authors declare no competing interests.
Keywords: Sex Difference; COVID-19; ITU; Mortality; Male; Immune System; Infection; Meta-Analysis; Review
Suggested Citation: Suggested Citation